Zhejiang Wolwo Bio-Pharmaceutical Soars in Innovative Drug Sector with Strategic Focus on Allergy Treatments
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd’s stock price has surged by over 14% as the company’s strategic focus on developing pharmaceutical products for allergic diseases drives growth in the innovative drug sector.
- Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read